Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Biochem J ; 387(Pt 3): 573-84, 2005 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-15683363

RESUMEN

The orexin-1 receptor interacts with beta-arrestin-2 in an agonist-dependent manner. In HEK-293T cells, these two proteins became co-internalized into acidic endosomes. Truncations from the C-terminal tail did not prevent agonist-induced internalization of the orexin-1 receptor or alter the pathway of internalization, although such mutants failed to interact with beta-arrestin-2 in a sustained manner or produce its co-internalization. Mutation of a cluster of three threonine and one serine residue at the extreme C-terminus of the receptor greatly reduced interaction and abolished co-internalization of beta-arrestin-2-GFP (green fluorescent protein). Despite the weak interactions of this C-terminally mutated form of the receptor with beta-arrestin-2, studies in wild-type and beta-arrestin-deficient mouse embryo fibroblasts confirmed that agonist-induced internalization of this mutant required expression of a beta-arrestin. Although without effect on agonist-mediated elevation of intracellular Ca2+ levels, the C-terminally mutated form of the orexin-1 receptor was unable to sustain phosphorylation of the MAPKs (mitogen-activated protein kinases) ERK1 and ERK2 (extracellular-signal-regulated kinases 1 and 2) to the same extent as the wild-type receptor. These studies indicate that a single cluster of hydroxy amino acids within the C-terminal seven amino acids of the orexin-1 receptor determine the sustainability of interaction with beta-arrestin-2, and indicate an important role of beta-arrestin scaffolding in defining the kinetics of orexin-1 receptor-mediated ERK MAPK activation.


Asunto(s)
Arrestinas/química , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Receptores de Neuropéptido/química , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Animales , Línea Celular , Activación Enzimática , Quinasas MAP Reguladas por Señal Extracelular/química , Fibroblastos/metabolismo , Humanos , Cinética , Ratones , Datos de Secuencia Molecular , Receptores de Orexina , Mutación Puntual , Receptores Acoplados a Proteínas G/química , Receptores Acoplados a Proteínas G/fisiología , Receptores de Neuropéptido/genética , Arrestina beta 2 , beta-Arrestinas
2.
Endocrinology ; 146(9): 3724-31, 2005 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15961555

RESUMEN

We investigated the effects of glucocorticoid manipulation on orexin-A-induced feeding and prepro-orexin mRNA levels in the lateral hypothalamic area (LHA) of the rat brain. Adrenalectomy (ADX) reduced orexin-A-induced feeding over 4 h by about 60%, compared with shams, an effect that was reversed by corticosterone (CORT) replacement. ADX had no effect on prepro-orexin mRNA levels in the LHA in either the morning or the evening; however, message was up-regulated by CORT in the morning but not the evening. An increased number of emulsion grains per cell in the LHA suggests that this is a specific increase in prepro-orexin mRNA and is not due to an increased number of cells expressing message. Prepro-orexin mRNA levels in the LHA were elevated 4 h after injection of lipopolysaccharide, compared with saline-injected controls. Partial but not complete abolition of orexin-A-induced feeding by ADX suggests that orexin-A-induced feeding may be mediated through glucocorticoid-dependent and glucocorticoid-independent pathways. In the morning increased prepro-orexin mRNA after CORT replacement demonstrates that orexin expression is sensitive to increased concentrations of glucocorticoids. However, the lack of effect of ADX on prepro-orexin mRNA levels suggests that endogenous glucocorticoids are not involved in tonic regulation of basal prepro-orexin expression. Overall our data constitute a body of evidence for an integrated relationship between central orexin expression, stress, glucocorticoid manipulation, and feeding patterns in the rat.


Asunto(s)
Antiinflamatorios/metabolismo , Corticosterona/metabolismo , Ingestión de Alimentos/fisiología , Péptidos y Proteínas de Señalización Intracelular/genética , Neuropéptidos/genética , Estrés Fisiológico/fisiopatología , Adrenalectomía , Animales , Antiinflamatorios/farmacología , Ritmo Circadiano/fisiología , Corticosterona/farmacología , Ingestión de Alimentos/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Expresión Génica/fisiología , Área Hipotalámica Lateral/efectos de los fármacos , Área Hipotalámica Lateral/fisiología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Sistema Hipotálamo-Hipofisario/fisiología , Péptidos y Proteínas de Señalización Intracelular/farmacología , Lipopolisacáridos/farmacología , Masculino , Neuropéptidos/farmacología , Orexinas , Sistema Hipófiso-Suprarrenal/efectos de los fármacos , Sistema Hipófiso-Suprarrenal/fisiología , ARN Mensajero/análisis , Ratas , Ratas Sprague-Dawley
3.
Brain Res Mol Brain Res ; 118(1-2): 10-23, 2003 Oct 21.
Artículo en Inglés | MEDLINE | ID: mdl-14559350

RESUMEN

We have recently shown that UDP-glucose, and some related UDP-sugars, are potent agonists of the novel G protein-coupled receptor GPR105 (recently re-named P2Y(14)). GPR105 is widely expressed throughout many brain regions and peripheral tissues of human and rodents, and couples to a pertussis toxin-sensitive G protein. To further characterise the role of GPR105, we demonstrate by immunohistochemistry with receptor-specific antiserum that GPR105 protein is widely distributed throughout the post mortem human brain where it is localised to glial cells, and specifically co-localises with astrocytes. Using quantitative RT-PCR we also show that GPR105 mRNA exhibits a restricted expression profile in an array of human cell lines and primary cells, with prominent expression detected in immune cells including neutrophils, lymphocytes, and megakaryocytic cells. To investigate the G protein selectivity of GPR105, we used chimeric Galpha subunits (Galpha(qi5), Galpha(qo5), and Galpha(qs5)) and an intracellular Ca(2+) mobilisation assay to demonstrate that GPR105 couples to Galpha subunits of the G(i/o) family but not to G(s) family proteins or to endogenous G(q/11) proteins in HEK-293 cells. Finally, we show that expression of GPR105 mRNA in the rat brain is up-regulated by immunologic challenge with lipopolysaccharide. Based on these observations, we propose that G(i/o)-coupled GPR105 might play an important role in peripheral and neuroimmune function in response to extracellular UDP-sugars.


Asunto(s)
Astrocitos/metabolismo , Encéfalo/metabolismo , Leucocitos/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Receptores Inmunológicos/metabolismo , Receptores Purinérgicos P2/metabolismo , Animales , Astrocitos/inmunología , Encéfalo/inmunología , Línea Celular , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/metabolismo , Subunidades alfa de la Proteína de Unión al GTP Gq-G11/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/inmunología , Glucosa/inmunología , Humanos , Inmunohistoquímica , Leucocitos/inmunología , Lipopolisacáridos/inmunología , Masculino , Neuroinmunomodulación/inmunología , Subunidades de Proteína/genética , Subunidades de Proteína/metabolismo , ARN Mensajero/metabolismo , Ratas , Receptores Acoplados a Proteínas G/genética , Receptores Acoplados a Proteínas G/inmunología , Receptores Inmunológicos/genética , Receptores Inmunológicos/inmunología , Receptores Purinérgicos P2/genética , Receptores Purinérgicos P2/inmunología , Receptores Purinérgicos P2Y , Regulación hacia Arriba/inmunología , Uridina Difosfato/inmunología
4.
Psychopharmacology (Berl) ; 177(1-2): 1-14, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15205870

RESUMEN

RATIONALE: Neuromedin-U (NmU) is an agonist at NMU1R and NMU2R. The brain distribution of NmU and its receptors, in particular NMU2R, suggests widespread central roles for NmU. In agreement, centrally administered NmU affects feeding behaviour, energy expenditure and pituitary output. Further central nervous system (CNS) roles for NmU warrant investigation. OBJECTIVES: To investigate the CNS role of NmU by mapping NMU1R and NMU2R mRNA and measuring the behavioural, endocrine, neurochemical and c-fos response to intracerebroventricular (i.c.v.) NmU. METHODS: Binding affinity and functional potency of rat NmU was determined at human NMU1R and NMU2R. Expression of NMU1R and NMU2R mRNA in rat and human tissue was determined using semi-quantitative reverse-transcription polymerase chain reaction. In in-vivo studies, NmU was administered i.c.v. to male Sprague-Dawley rats, and changes in grooming, motor activity and pre-pulse inhibition (PPI) were assessed. In further studies, plasma endocrine hormones, [DOPAC + HVA]/[dopamine] and [5-HIAA]/[5-HT] ratios and levels of Fos-like immunoreactivity (FLI) were measured 20 min post-NmU (i.c.v.). RESULTS: NmU bound to NMU1R ( K(I), 0.11+/-0.02 nM) and NMU2R ( K(I), 0.21+/-0.05 nM) with equal affinity and was equally active at NMU1R (EC(50), 1.25+/-0.05 nM) and NMU2R (EC(50), 1.10+/-0.20 nM) in a functional assay. NMU2R mRNA expression was found at the highest levels in the CNS regions of both rat and human tissues. NMU1R mRNA expression was restricted to the periphery of both species with the exception of the rat amygdala. NmU caused a marked increase in grooming and motor activity but did not affect PPI. Further, NmU decreased plasma prolactin but did not affect levels of corticosterone, luteinising hormone or thyroid stimulating hormone. NmU elevated levels of 5-HT in the frontal cortex and hypothalamus, with decreased levels of its metabolites in the hippocampus and hypothalamus, but did not affect dopamine function. NmU markedly increased FLI in the nucleus accumbens, frontal cortex and central amygdala. CONCLUSIONS: These data provide further evidence for widespread roles for NmU and its receptors in the brain.


Asunto(s)
Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/metabolismo , Proteínas de la Membrana/agonistas , Proteínas de la Membrana/metabolismo , Neuropéptidos/administración & dosificación , Receptores de Neurotransmisores/agonistas , Receptores de Neurotransmisores/metabolismo , Animales , Línea Celular , Relación Dosis-Respuesta a Droga , Humanos , Inyecciones Intraventriculares , Ratas , Ratas Sprague-Dawley , Porcinos
5.
Regul Pept ; 104(1-3): 1-9, 2002 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-11830270

RESUMEN

Neurons expressing prepro-orexin, the precursor of orexin-A and -B, are found in the lateral hypothalamic area, a region classically implicated in driving feeding. Orexin-A induces feeding transiently when injected centrally, and food intake can be decreased when orexin action is disrupted by immunoneutralization of orexin-A, or by pharmacological blockade of orexin receptors, or by transgenic knockout of orexin. Here, we argue that orexin neurons may act to stimulate feeding in the short term, and that important regulatory signals may be a fall in plasma glucose (stimulatory), countered by satiety signals generated by eating, such as gastric distention (inhibitory).


Asunto(s)
Proteínas Portadoras/fisiología , Ingestión de Alimentos/fisiología , Área Hipotalámica Lateral/metabolismo , Péptidos y Proteínas de Señalización Intracelular , Neuronas/metabolismo , Neuropéptidos/fisiología , Animales , Glucemia/fisiología , Proteínas Portadoras/biosíntesis , Humanos , Hambre/fisiología , Leptina/fisiología , Neuropéptidos/biosíntesis , Orexinas , Respuesta de Saciedad/fisiología
6.
Water Res ; 38(6): 1559-67, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15016533

RESUMEN

The effect of nutrient removal at Ashford sewage treatment works on the benthic diatom ecology of the River Stour was studied. This paper describes assemblages above and below the works both before and after phosphorus stripping was installed. Taxa typical of eutrophic conditions dominated all samples, including those upstream of the works, suggesting that the river was already eutrophic before receiving the sewage effluent. Once nutrient removal was installed, phosphorus concentrations measured downstream of the works were similar to those measured upstream; however, there was little change in the diatom flora. Analysis of chemical data collected from the site suggest that the river may be nitrogen-limited for part of the year, and that, even with phosphorus stripping installed, the river still exceeds the Environment Agency's proposed interim targets for phosphorus concentrations in a eutrophic river.


Asunto(s)
Diatomeas , Eutrofización , Fósforo/aislamiento & purificación , Eliminación de Residuos Líquidos/métodos , Agua/química , Ciudades , Dinámica Poblacional , Ríos , Aguas del Alcantarillado/química , Purificación del Agua
7.
Bioorg Med Chem Lett ; 16(18): 4865-71, 2006 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-16839761

RESUMEN

We report here the discovery of a class of MCH R1 ligands based on a biphenyl carboxamide template. A docked-in model is presented indicating key interactions in the putative binding site of the receptor. Parallel high throughput synthetic techniques were utilised to allow rapid exploration of the structure-activity relationship around this template, leading to compound SB-568849 which possessed good receptor affinity and selectivity. This compound proved to be an antagonist with stability in vivo, an acceptable brain-blood ratio and oral bioavailability.


Asunto(s)
Amidas/química , Amidas/farmacología , Compuestos de Bifenilo/síntesis química , Compuestos de Bifenilo/farmacología , Receptores de Somatostatina/antagonistas & inhibidores , Amidas/síntesis química , Amidas/farmacocinética , Animales , Compuestos de Bifenilo/química , Compuestos de Bifenilo/farmacocinética , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Bovinos , Biología Computacional , Humanos , Ligandos , Modelos Moleculares , Estructura Molecular , Receptores de Somatostatina/química , Receptores de Somatostatina/metabolismo , Relación Estructura-Actividad , Azufre/química
8.
Eur J Neurosci ; 15(2): 315-28, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11849298

RESUMEN

The neuropeptides orexin-A and orexin-B are produced in neurons of the lateral hypothalamic area and have been implicated to be involved in the regulation of food/water intake and sleep-wake control. The orexins act at two different G-protein-coupled orexin receptors (OX-R1 and OX-R2) that are derived from separate genes and expressed differentially throughout the central nervous system. In the present study, we have used a polyclonal antipeptide antiserum to analyse in detail the distribution of OX-R1-immunoreactive neurons in the rat hypothalamus. In order to identify the chemical mediators of orexin action in the hypothalamus, the OX-R1-containing neurons were characterized with regard to the content of peptides shown previously to affect ingestive and drinking behaviour. Neurons containing OX-R1 immunoreactivity were widely distributed in the hypothalamus with cell bodies located in the suprachiasmatic, periventricular, paraventricular (both magno- and parvocellular division), supraoptic, arcuate, ventromedial, dorsomedial and tuberomammillary nuclei and the lateral hypothalamic area. In magnocellular neurons of the paraventricular and supraoptic nuclei, OX-R1 immunoreactivity was seen in both vasopressin- and oxytocin-containing neurons. OX-R1 immunoreactivity was demonstrated in vasopressin and vasoactive intestinal polypeptide (VIP) neurons of the suprachiasmatic nucleus, in somatostatin neurons of the periventricular nucleus and in corticotropin-releasing hormone (CRH) neurons of the parvocellular paraventricular nucleus. In the arcuate nucleus, OX-R1 immunoreactivity was present in neuropeptide Y (NPY) and agouti-related peptide (AGRP) neurons of the ventromedial part as well as in proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) neurons of the ventrolateral division. In the lateral hypothalamic area, OX-R1 immunoreactivity was demonstrated in melanin-concentrating hormone (MCH)- and orexin-containing neurons. In the hypothalamic tuberomammillary nucleus, OX-R1-immunoreactivity was shown in many histamine-containing neurons. The results support the idea that orexins have important actions on hypothalamic neurons that control food intake and fluid balance, but also that orexins may regulate other neuroendocrine systems.


Asunto(s)
Ingestión de Líquidos/fisiología , Ingestión de Alimentos/fisiología , Hipotálamo/química , Neuronas/química , Receptores de Neuropéptido/análisis , Secuencia de Aminoácidos , Animales , Especificidad de Anticuerpos , Hipotálamo/citología , Hipotálamo/fisiología , Inmunohistoquímica , Masculino , Datos de Secuencia Molecular , Receptores de Orexina , Conejos , Ratas , Ratas Sprague-Dawley , Receptores Acoplados a Proteínas G , Receptores de Neuropéptido/inmunología
9.
J Biol Chem ; 278(11): 9869-74, 2003 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-12522134

RESUMEN

Nicotinic acid has been used clinically for over 40 years in the treatment of dyslipidemia producing a desirable normalization of a range of cardiovascular risk factors, including a marked elevation of high density lipoprotein and a reduction in mortality. The precise mechanism of action of nicotinic acid is unknown, although it is believed that activation of a G(i)-G protein-coupled receptor may contribute. Utilizing available information on the tissue distribution of nicotinic acid receptors, we identified candidate orphan receptors. The selected orphan receptors were screened for responses to nicotinic acid, in an assay for activation of G(i)-G proteins. Here we describe the identification of the G protein-coupled receptor HM74 as a low affinity receptor for nicotinic acid. We then describe the subsequent identification of HM74A in follow-up bioinformatics searches and demonstrate that it acts as a high affinity receptor for nicotinic acid and other compounds with related pharmacology. The discovery of HM74A as a molecular target for nicotinic acid may facilitate the discovery of superior drug molecules to treat dyslipidemia.


Asunto(s)
Niacina/farmacología , Receptores Nicotínicos/química , Secuencia de Aminoácidos , Animales , Células CHO , Membrana Celular/metabolismo , Cricetinae , ADN Complementario/metabolismo , Bases de Datos como Asunto , Relación Dosis-Respuesta a Droga , Femenino , Furanos/farmacología , Humanos , Hiperlipidemias/metabolismo , Hipolipemiantes/farmacología , Concentración 50 Inhibidora , Masculino , Datos de Secuencia Molecular , Niacina/química , Oocitos/metabolismo , Unión Proteica , Pirazinas/farmacología , ARN Mensajero/metabolismo , Ratas , Receptores Nicotínicos/metabolismo , Homología de Secuencia de Aminoácido , Distribución Tisular , Xenopus
10.
J Biol Chem ; 278(13): 11312-9, 2003 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-12496283

RESUMEN

GPR41 and GPR43 are related members of a homologous family of orphan G protein-coupled receptors that are tandemly encoded at a single chromosomal locus in both humans and mice. We identified the acetate anion as an agonist of human GPR43 during routine ligand bank screening in yeast. This activity was confirmed after transient transfection of GPR43 into mammalian cells using Ca(2+) mobilization and [(35)S]guanosine 5'-O-(3-thiotriphosphate) binding assays and by coexpression with GIRK G protein-regulated potassium channels in Xenopus laevis oocytes. Other short chain carboxylic acid anions such as formate, propionate, butyrate, and pentanoate also had agonist activity. GPR41 is related to GPR43 (52% similarity; 43% identity) and was activated by similar ligands but with differing specificity for carbon chain length, with pentanoate being the most potent agonist. A third family member, GPR42, is most likely a recent gene duplication of GPR41 and may be a pseudogene. GPR41 was expressed primarily in adipose tissue, whereas the highest levels of GPR43 were found in immune cells. The identity of the cognate physiological ligands for these receptors is not clear, although propionate is known to occur in vivo at high concentrations under certain pathophysiological conditions.


Asunto(s)
Ácidos Carboxílicos/farmacología , Propionatos/farmacología , Receptores de Superficie Celular/agonistas , Receptores Acoplados a Proteínas G , Secuencia de Aminoácidos , Animales , Cartilla de ADN , Humanos , Inmunohistoquímica , Datos de Secuencia Molecular , Receptores de Superficie Celular/metabolismo , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/metabolismo , Xenopus laevis
11.
J Biol Chem ; 278(13): 11303-11, 2003 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-12496284

RESUMEN

GPR40 is a member of a subfamily of homologous G protein-coupled receptors that include GPR41 and GPR43 and that have no current function or ligand ascribed. Ligand fishing experiments in HEK293 cells expressing human GPR40 revealed that a range of saturated and unsaturated carboxylic acids with carbon chain lengths greater than six were able to induce an elevation of [Ca(2+)](i), measured using a fluorometric imaging plate reader. 5,8,11-Eicosatriynoic acid was the most potent fatty acid tested, with a pEC(50) of 5.7. G protein coupling of GPR40 was examined in Chinese hamster ovary cells expressing the G alpha(q/i)-responsive Gal4-Elk1 reporter system. Expression of human GPR40 led to a constitutive induction of luciferase activity, which was further increased by exposure of the cells to eicosatriynoic acid. Neither the constitutive nor ligand-mediated luciferase induction was inhibited by pertussis toxin treatment, suggesting that GPR40 was coupled to G alpha(q/11.) Expression analysis by quantitative reverse transcription-PCR showed that GPR40 was specifically expressed in brain and pancreas, with expression in rodent pancreas being localized to insulin-producing beta-cells. These data suggest that some of the physiological effects of fatty acids in pancreatic islets and brain may be mediated through a cell-surface receptor.


Asunto(s)
Ácidos Grasos/farmacología , Receptores de Superficie Celular/efectos de los fármacos , Receptores de Superficie Celular/metabolismo , Receptores Acoplados a Proteínas G , Animales , Secuencia de Bases , Calcio/metabolismo , Línea Celular , Clonación Molecular , Cricetinae , Cartilla de ADN , Ácidos Grasos/genética , Humanos , Hibridación in Situ , Luciferasas/genética , Datos de Secuencia Molecular , Receptores de Superficie Celular/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA